Centa Longevity
Longevity clinic using multimodal biomarkers to assess and treat biological aging.
Company Overview
Snapshot
Founded in December 2025, Centa Longevity operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on establishing its advanced diagnostics and treatment protocols.
Business overview
Centa Longevity is an Israeli longevity clinic and aging research company specializing in advanced diagnostics and treatments for biological aging. The company utilizes a multimodal approach, integrating molecular, serum, imaging, and functional measurements to create detailed biological age profiles based on hundreds of biomarkers. Proprietary algorithms analyze this data to identify risk factors and develop personalized prevention and rejuvenation programs. Centa Longevity offers evidence-based, clinically vetted interventions across preventative, functional, and molecular domains to mitigate aging-related decline, aiming to reduce disease risk and extend healthy lifespans for its clients within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Digital Medical Diagnostics.
Company Intelligence Q&A
- What is Centa Longevity's primary focus?
- Centa Longevity is an Israeli longevity clinic and aging research company focused on providing advanced diagnostics and treatments to address biological aging.
- When was Centa Longevity founded?
- Centa Longevity was founded in December 2025.
- What is Centa Longevity's current funding stage?
- Centa Longevity is currently in a Pre-Funding stage, focusing on establishing its advanced diagnostics and treatment protocols.
- How does Centa Longevity assess biological age?
- Centa Longevity assesses biological age using a multimodal approach that combines molecular, serum, imaging, and functional measurements to build a detailed biological age profile based on hundreds of biomarkers.
- What kind of interventions does Centa Longevity offer?
- Centa Longevity offers evidence-based, clinically vetted interventions across preventative, functional, and molecular domains to slow or reverse aging-related decline.